Biocartis

 

Biocartis and Fast Track diagnostics signed an agreement in May 2015. Together, they aim to develop a broad range of infectious disease tests based on the approach of ’syndromic multiplex testing’ for use on Biocartis’ innovative molecular diagnostics (MDx) platform, Idylla™. The Idylla™ platform is a fully automated, real-time PCR based molecular diagnostics system, which covers the entire process from sample to result in a time frame of 35 to 150 minutes with less than 2 minutes hands-on time. Idylla™ is applicable for a wide range of clinical sample types and can analyze both RNA and DNA. This fully integrated system is designed to offer fast and easy access to clinical molecular diagnostic information, anywhere and anytime.

The first test to develop under this collaboration is the Idylla™ Respiratory Mixed Panel Test. The purpose of the project is to develop an assay on the IdyllaTM platform that detects a wide range of different respiratory viruses and bacteria. Further tests for the diagnosis of other pathogens are in development.

 

Biocartis logo_For description page use only